Levamisole (150 mg per day) vs placebo
Decrease in frequency of attacks · Participants with a previous or current history of recurrent aphthous stomatitis (RAS), diagnosed on history and clinical examination;…
Levamisole (150 mg per day) showed no clear difference in decrease in frequency of attacks compared with placebo; GRADE not reported.
1 finding from 1 review
- Systemic interventions for recurrent aphthous stomatitis (mouth ulcers) 2012 · Cochrane All outcomesRR 4.29 [0.72, 25.39]1 studyGRADE not reported